Published in Environ Ecol Stat on March 01, 2009
Nonparametric estimation of benchmark doses in environmental risk assessment. Environmetrics (2012) 1.02
Maximum likelihood estimation with binary-data regression models: small-sample and large-sample features. Adv Appl Stat (2010) 0.93
Benchmark Dose Analysis via Nonparametric Regression Modeling. Risk Anal (2013) 0.77
The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer (1954) 11.33
A new method for determining allowable daily intakes. Fundam Appl Toxicol (1984) 3.53
Confidence intervals and test of hypotheses concerning dose response relations inferred from animal carcinogenicity data. Biometrics (1977) 1.51
Confidence bands for low-dose risk estimation with quantal response data. Biometrics (2003) 1.31
Biostatistical issues in the design and analysis of animal carcinogenicity experiments. Environ Health Perspect (1994) 1.25
Upper confidence limits on excess risk for quantitative responses. Risk Anal (1993) 1.13
Multiplicity-adjusted inferences in risk assessment: benchmark analysis with quantal response data. Biometrics (2005) 1.12
Estimating upper confidence limits for extra risk in quantal multistage models. Risk Anal (1994) 1.03
Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food Cosmet Toxicol (1974) 1.02
Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. Risk Anal (2003) 0.97
Limitations to empirical extrapolation studies: the case of BMD ratios. Risk Anal (2001) 0.83
Estimating risk assessment exposure point concentrations when the data are not normal or lognormal. Risk Anal (1999) 0.81
On use of the multistage dose-response model for assessing laboratory animal carcinogenicity. Regul Toxicol Pharmacol (2007) 1.56
Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity. Environ Mol Mutagen (2012) 1.38
Confidence bands for low-dose risk estimation with quantal response data. Biometrics (2003) 1.31
Multiplicity-adjusted inferences in risk assessment: benchmark analysis with quantal response data. Biometrics (2005) 1.12
Simultaneous Confidence Bands for Abbott-Adjusted Quantal Response Models. Stat Methodol (2008) 0.98
Maximum likelihood estimation with binary-data regression models: small-sample and large-sample features. Adv Appl Stat (2010) 0.93
The Impact of Model Uncertainty on Benchmark Dose Estimation. Environmetrics (2012) 0.87
A sensitivity analysis of the social vulnerability index. Risk Anal (2008) 0.86
Confidence limits on one-stage model parameters in benchmark risk assessment. Environ Ecol Stat (2009) 0.86
Detection of oxidative DNA damage in isolated marine bivalve hemocytes using the comet assay and formamidopyrimidine glycosylase (Fpg). Mutat Res (2003) 0.81
Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study. J Womens Health (Larchmt) (2004) 0.77
Benchmark dose profiles for joint-action quantal data in quantitative risk assessment. Biometrics (2012) 0.76
Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin? Breast Cancer Res Treat (2006) 0.76
Benchmark dose profiles for joint-action continuous data in quantitative risk assessment. Biom J (2013) 0.75
Ergonomic decision-making: a conceptual framework for experienced practitioners from backgrounds in industrial engineering and physical therapy. Appl Ergon (2006) 0.75